Diabetes, hyperlipidemia, and hypertension are modifiable risk factors that predict
cardiovascular disease events. The effect of these risk factors on incident cardiovascular …

The 2018 and 2019 guidelines from the American College of Cardiology and American
Heart Association reflect the complexity of individualized cholesterol management. The …

Objective To develop clinical practice guidelines for the primary prevention of atherosclerotic
cardiovascular disease (ASCVD) and type 2 diabetes mellitus (T2DM) in individuals at …

Importance A better understanding of the role of atherosclerosis in the development of
ischemic stroke subtypes could help to improve strategies for prevention of stroke …

Background: Mindfulness-based art therapy (MBAT) induces emotional relaxation in
coronary artery disease (CAD) patients, and is a treatment known to improve psychological …

Determining optimal candidates for the numerous potential pharmacotherapies for primary
prevention of atherosclerotic cardiovascular disease remains challenging. Selective use of …

Clinical guidelines for instituting pharmacotherapy for the primary prevention of
atherosclerotic cardiovascular disease (ASCVD), specifically lipid management and aspirin …

Background Cardiovascular disease (CVD), mainly heart attack and stroke, is the leading
cause of premature mortality in low and middle income countries (LMICs). Identifying and …

Ожирение является одним из важных факторов риска сердечно-сосудистых
заболеваний. Эпидемию ожирения связывают с изменениями в социальной …

Despite the success of statin therapy in reducing atherosclerotic cardiovascular disease
(ASCVD), there remains a large residual risk for recurrent events in statin-treated patients …